Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion
about
Cytidine 5'-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future PerspectivesThe role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectivesLabel-free CEST MRI Detection of Citicoline-Liposome Drug Delivery in Ischemic StrokeEight weeks of citicoline treatment does not perturb sleep/wake cycles in cocaine-dependent adults.Donepezil in Alzheimer's disease: From conventional trials to pharmacogeneticsTranscranial doppler ultrasound blood flow velocity and pulsatility index as systemic indicators for Alzheimer's diseaseThe relation of dietary choline to cognitive performance and white-matter hyperintensity in the Framingham Offspring CohortGenomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics.Retrospective and observational study to assess the efficacy of citicoline in elderly patients suffering from stupor related to complex geriatric syndrome.Genetics in clinical trials.Age Drives Distortion of Brain Metabolic, Vascular and Cognitive Functions, and the Gut Microbiome.Citicoline – a neuroprotector with proven effects on glaucomatous disease.Effects of Liposomal Formulation of Citicoline in Experimental Diabetes-Induced Retinal Neurodegeneration
P2860
Q26775083-E200F926-5E51-4329-8FA0-EFDC34F30C5AQ26781186-D00A2B87-A524-4B00-94BD-C7ECDD5CAB21Q28829493-92F26EA3-0BE6-4AE0-95C3-A3ECA31AB0BAQ34852058-2AAE8ED2-84EF-415F-A92D-881D861F2F43Q34965949-AD158760-8832-438E-B673-16D5F9E87950Q35050916-A8240160-9057-490C-994B-24A64ACF9F78Q35656447-679A0A54-912D-40F7-9115-0B99FE53BAADQ35852564-3FFDB0F2-E875-4E5D-B083-C997683B1A76Q35997472-326A26A2-7180-4AD2-891E-5506119B2960Q37462565-7AB2BBDA-5A28-4B00-B167-C8C839DBD0AEQ42367849-3F52682B-A09A-481B-B265-DD52508B63EAQ47100745-D9CD3CF4-7714-4F09-87A9-729D7E8344C0Q58734085-69B2FFAD-2FBB-4F06-9483-581DA2044ED9
P2860
Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Double-blind placebo-controlle ...... ctivity and cerebral perfusion
@ast
Double-blind placebo-controlle ...... ctivity and cerebral perfusion
@en
Double-blind placebo-controlle ...... ctivity and cerebral perfusion
@nl
type
label
Double-blind placebo-controlle ...... ctivity and cerebral perfusion
@ast
Double-blind placebo-controlle ...... ctivity and cerebral perfusion
@en
Double-blind placebo-controlle ...... ctivity and cerebral perfusion
@nl
prefLabel
Double-blind placebo-controlle ...... ctivity and cerebral perfusion
@ast
Double-blind placebo-controlle ...... ctivity and cerebral perfusion
@en
Double-blind placebo-controlle ...... ctivity and cerebral perfusion
@nl
P2093
P921
P3181
P1476
Double-blind placebo-controlle ...... ctivity and cerebral perfusion
@en
P2093
J J Secades
L Fernández-Novoa
R Cacabelos
P304
P3181
P407
P577
1999-11-01T00:00:00Z